Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by...

FDA Recall #D-0220-2024 — Class I — November 17, 2023

Recall #D-0220-2024 Date: November 17, 2023 Classification: Class I Status: Completed

Product Description

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

Reason for Recall

Defective Container: powder may leak out of the pouch

Recalling Firm

InvaGen Pharmaceuticals, Inc. — Central Islip, NY

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

1240 boxes

Distribution

Nationwide within the United States

Code Information

Lot #: NB301030, Exp. Date 03/31/2025

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated